Only two and a half months into the new year, the measles cases recorded from the U.S. have already surpassed the total cases ...

Merck (MRK) stock trended lower as Halozyme (HALO) challenges the company over injectable Keytruda patents. Read more here.

The Texas Department of State Health Services announced Tuesday that the state’s ongoing measles outbreak has led to 159 cases, including 22 hospitalizations and one fatality, since late January. The ...

A certified medical assistant holds needles full of the HPV vaccination drug Gardasil before administering them to children at a health center in Texas. Photo: Matthew Busch for The Washington Post ...

The health secretary has since told lawmakers that he has referred hundreds of clients to the law firm suing vaccine-maker ...

Merck (NYSE:MRK) shares snaps six straight sessions of gains, as the stock closed 2.2% lower at $89.38 on Wednesday. The cancer drugmaker gained about 10% in the preceding six sessions. The stock ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Mer­ck said its “once-in-a-life­time” drug Keytru­da could be sub­ject to price re­duc­tions un­der the In­fla­tion Re­duc­tion Act, which would lead to a … ...

She will become executive director of global public policy and stakeholder engagement with Merck Animal Health. Bucko’s final day at USDA is March 7. The Food and Drug Administration named ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Feb 25 (Reuters) - Drugmaker Merck (MRK.N), opens new tab said on Tuesday it expects its top selling cancer therapy Keytruda to be selected in 2026 for government price setting, which would become ...